Publications by authors named "Taisuke Hamamoto"

Claim this Profile
S
Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.
Tetsuo Asaki, Keiichi Kuwano, Keith Morrison, John Gatfield, Taisuke Hamamoto

J Med Chem· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Tomiyoshi Aoki, Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, Shinji Ohmachi

Bioorg Med Chem Lett· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor alpha (PPARalpha) agonists.
Tetsuo Asaki, Tomiyoshi Aoki, Taisuke Hamamoto, Yukiteru Sugiyama, Shinji Ohmachi

Bioorg Med Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists.
Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, Kenji Kuwabara

Bioorg Med Chem Lett· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies on diphenylpyrazine derivatives: a novel class of prostacyclin receptor agonists.
Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, Kenji Kuwabara

Bioorg Med Chem· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-[4-[(5,6-diphenylpyrazin-2-yl)(isopropyl)amino]butoxy]-N-(methylsulfonyl)acetamide (NS-304), an orally available and long-acting prostacyclin receptor agonist prodrug.
Keiichi Kuwano, Asami Hashino, Tetsuo Asaki, Taisuke Hamamoto, Tetsuhiro Yamada

J Pharmacol Exp Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors.
Tetsuo Asaki, Yukiteru Sugiyama, Taisuke Hamamoto, Masaya Higashioka, Masato Umehara

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis